Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back



Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer) free to download

Volume:13   Issue:2
Pp: 117-120
Jiezhong Chen
DOI: 10.2174/1568009611313020001

Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma

Volume:13   Issue:2
Pp: 126-142
Daniel C. Cho and James W. Mier
DOI: 10.2174/1568009611313020003

Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer

Volume:13   Issue:2
Pp: 143-156
Jianghong Wu, Chen Chen and Kong-Nan Zhao
DOI: 10.2174/1568009611313020004

The PI3 Kinase Signaling Pathway in Prostate Cancer

Volume:13   Issue:2
Pp: 157-164
Aymen A. Elfiky and Zhenyang Jiang
DOI: 10.2174/1568009611313020005

Studies of NVP-BEZ235 in Melanoma

Volume:13   Issue:2
Pp: 165-174
Joshua A. Sznol, Lucia B. Jilaveanu and Harriet M. Kluger
DOI: 10.2174/1568009611313020006

Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer open access plus

Volume:13   Issue:2
Pp: 175-187
Xiaobei Zhang, Xi-ru Li and Jin Zhang
DOI: 10.2174/1568009611313020007

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling open access plus

Volume:13   Issue:2
Pp: 188-204
Thomas W. Grunt and Gabriella L. Mariani
DOI: 10.2174/1568009611313020008

Current and Potential Treatments for Cervical Cancer

Volume:13   Issue:2
Pp: 205-220
Grace P.C. Yee, Paul de Souza and Levon M. Khachigian
DOI: 10.2174/1568009611313020009

The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas

Volume:13   Issue:2
Pp: 221-231
Hailin Tang, Yanhui Bian, Chaofeng Tu, Zeyou Wang, Zhibin Yu, Qing Liu, Gang Xu, Minghua Wu and Guiyuan Li
DOI: 10.2174/1568009611313020010